GC19385
XMD16-5
Also known as 2-[4-(4-hydroxypiperidin-1-yl)anilino]-11-methyl-5H-pyrimido[4,5-b][1,4]benzodiazepin-6-one
XMD16-5 is a potent TNK2 inhibitor with IC50 values of 16 and 77 nM for the D163E and R806Q mutations, respectively
ChemicalCAS1345098-78-3MW416.48FormulaC23H24N6O2
- CAS number
- 1345098-78-3
- Molecular weight
- 416.48
- Formula
- C23H24N6O2
- Solubility
- DMSO ： ≥ 29 mg/mL (69·63 mM)
- InChIKey
- AGLKBEPKKDHHKY-UHFFFAOYSA-N
- Catalogue number
- GC19385
- Brand
- GLPBIO
Computed properties PubChem CID 57340666 · XLogP 3 · TPSA 93.6 Ų · H-bond donors 3
- XLogP
- 3
- TPSA
- 93.6 Ų
- H-bond donors
- 3
- H-bond acceptors
- 7
- Rotatable bonds
- 3
- Heavy atoms
- 31
SMILES CN1C2=CC=CC=C2C(=O)NC3=CN=C(N=C31)NC4=CC=C(C=C4)N5CCC(CC5)O
Computed descriptors from PubChem (CID 57340666), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il